Hhlr Advisors, Ltd. Hookipa Pharma Inc. Transaction History

Hhlr Advisors, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.71 - $1.97 $547,209 - $1.52 Million	770,717 New	770,717 $678,000
Q3 2021 Nov 15, 2021	SELL	$5.89 - $9.35 $1.59 Million - $2.52 Million	-269,368 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$9.16 - $19.51 $4.27 Million - $9.1 Million	-466,202 Reduced 63.38%	269,368 $2.47 Million
Q1 2021 May 17, 2021	SELL	$10.64 - $14.7 $2.21 Million - $3.05 Million	-207,684 Reduced 22.02%	735,570 $9.89 Million
Q3 2019 Nov 14, 2019	BUY	$6.45 - $8.44 $4.24 Million - $5.55 Million	657,540 Added 230.14%	943,254 $7.07 Million
Q2 2019 Aug 14, 2019	BUY	$6.16 - $14.15 $1.76 Million - $4.04 Million	285,714 New	285,714 $1.92 Million

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.